Delivery Order SPE2DX15D2012-SPE2DX24F7TE0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,832.48 for the supply of 4 mg Glimepiride tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,330.04 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,247.78 firm fixed-price delivery order is for the supply of Glimepiride 4 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,316.49 Firm Fixed Price Delivery Order covers the supply of 4,567,751,489 units of the generic drug Glimepiride 2 mg tablets. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $1,018.25 firm fixed-price delivery order is for 4566437277 GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, Corporate Office Division, a firm-fixed-price delivery order contract valued at $1,286.16 for the supply of 4,565,784,148 glimepiride 4 mg tablets. The contract has a completion date of September 13, 2024 and was awarded on September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and supplier of medical products to the U.S. federal government. This delivery order is part of the company's broader...
- This federal contract award is for the delivery of 4,564,931,294 units of the drug Glimepiride 1 mg tablets, with a ceiling value of $4,046.78, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award is a Delivery Order worth $1,176.98 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is for 4,567,171,215 tablets of the drug Glimepiride 4 mg. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The award has a ceiling value of $2,985.41 and a period of performance through April 10, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The U.S. government has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Glimepiride 4 mg tablets. The contract, valued at $1,343.40, is funded by the Defense Logistics Agency (DLA), a defense agency. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to...
- SPE2DX15D2012Indefinite Delivery Contract
- SPE2DX15D2012-SPE2DX24F7TE0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,035.05 for the supply of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 6, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This particular award for glimepiride tablets is a discrete delivery order placed against the larger IDC. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 12/5/23 |